There were no significant differences between the two groups with regard to age, sex, smoking status, PS, the proportion of patients with EGFR mutation status, adrenal gland metastasis, bone metastasis, liver metastasis, or CNS metastasis with or without unstable symptoms. The gene discussed is EGFR; the disease is bone metastasis.